These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16495248)

  • 1. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.
    Bogdanovich T; Bozdogan B; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):893-8. PubMed ID: 16495248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates.
    Peric M; Bozdogan B; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1017-22. PubMed ID: 12604536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.
    Fuchs PC; Barry AL; Brown SD
    J Clin Microbiol; 2001 Jan; 39(1):43-6. PubMed ID: 11136745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.
    De Vecchi E; Nicola L; Larosa M; Drago L
    BMC Microbiol; 2008 Jan; 8():23. PubMed ID: 18230154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
    Drago L; De Vecchi E; Nicola L; Colombo A; Gismondo MR
    J Antimicrob Chemother; 2004 Aug; 54(2):542-5. PubMed ID: 15215227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli.
    Cagliero C; Mouline C; Payot S; Cloeckaert A
    J Antimicrob Chemother; 2005 Nov; 56(5):948-50. PubMed ID: 16157618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens.
    Drago L; De Vecchi E; Nicola L; Legnani D; Gismondo MR
    APMIS; 2005 Oct; 113(10):655-63. PubMed ID: 16309423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of five quinolones, three macrolides and telithromycin against 12 Haemophilus influenzae strains with different resistance phenotypes.
    Pankuch GA; Lin G; Appelbaum PC
    Clin Microbiol Infect; 2005 Dec; 11(12):1040-4. PubMed ID: 16307562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin.
    Bouchillon SK; Johnson JL; Hoban DJ; Stevens TM; Johnson BM
    J Antimicrob Chemother; 2005 Jul; 56(1):224-7. PubMed ID: 15890718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S.
    Peric M; Bozdogan B; Galderisi C; Krissinger D; Rager T; Appelbaum PC
    J Antimicrob Chemother; 2004 Aug; 54(2):393-400. PubMed ID: 15243030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.
    Clark C; Bozdogan B; Peric M; Dewasse B; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2956-62. PubMed ID: 12183253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [in vitro activity of telithromycin against Haemophilus influenzae].
    Dabernat H; Seguy M; Delmas C
    Pathol Biol (Paris); 2002 Feb; 50(1):58-62. PubMed ID: 11873632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance.
    Burgess DS; Hastings RW; Horan JL
    Ann Pharmacother; 1999 Dec; 33(12):1262-5. PubMed ID: 10630825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary.
    Zhanel GG; Johanson C; Laing N; Hisanaga T; Wierzbowski A; Hoban DJ
    Antimicrob Agents Chemother; 2005 May; 49(5):1943-8. PubMed ID: 15855517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.